Beijing Bohui Innovation Biotechnology Group Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Zhiwei Shen

Algemeen directeur

CN¥1.6m

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	1.4yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	1.4yrs
Gemiddelde ambtstermijn bestuur	3.4yrs

Recente managementupdates

Recent updates

We Think Beijing Bohui Innovation Biotechnology Group (SZSE:300318) Is Taking Some Risk With Its Debt

Sep 30

CEO

Zhiwei Shen (46 yo)

1.4yrs

Tenure

CN¥1,595,400

Compensatie

Mr. Zhiwei Shen has been Chairman and Non-Independent Director at Beijing Bohui Innovation Biotechnology Group Co., Ltd. (formerly known as Beijing Bohui Innovation Biotechnology Co., Ltd.) since June 01,...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Zhiwei Shen	Chairman of the Board & GM	1.4yrs	CN¥1.60m	geen gegevens
Jia Liu	Financial Director	1.4yrs	CN¥536.00k	geen gegevens
Haifeng Dong	Deputy GM	4.3yrs	CN¥834.70k	geen gegevens
Sixu Chen	Accounting Supervisor	no data	geen gegevens	geen gegevens

1.4yrs

Gemiddelde duur

40yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 300318 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.4 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Zhiwei Shen	Chairman of the Board & GM	4.4yrs	CN¥1.60m	geen gegevens
Haifeng Dong	Deputy GM	2.4yrs	CN¥834.70k	geen gegevens
Jianghong Du	Chairman of the Supervisory Board	10.5yrs	geen gegevens	3% CN¥ 142.2m
Jun Ban	Independent Director	4.4yrs	CN¥100.00k	geen gegevens
Xiaosu Zhang	Independent Director	4.4yrs	CN¥100.00k	geen gegevens
Lanlan Hu	Employee Representative Supervisor	4.4yrs	geen gegevens	0.00034% CN¥ 16.1k
Jun Yin	Independent Director	1.4yrs	CN¥50.40k	geen gegevens
Yong Shen	Non-Independent Director	1.4yrs	geen gegevens	geen gegevens
Chenglin Zeng	Non-Independent Director	1.4yrs	CN¥1.40m	geen gegevens
Hengfei Xu	Non-Employee Supervisor	1.4yrs	geen gegevens	geen gegevens

3.4yrs

Gemiddelde duur

55.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 300318 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.4 jaar).

Beijing Bohui Innovation Biotechnology Group Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Beijing Bohui Innovation Biotechnology Group Co., Ltd., Annual General Meeting, May 17, 2024

High number of new directors

Beijing Bohui Innovation Biotechnology Group Co., Ltd., Annual General Meeting, Jun 29, 2023

Less than half of directors are independent

Beijing Bohui Innovation Biotechnology Group Co., Ltd., Annual General Meeting, Jun 24, 2022

High number of new and inexperienced directors

Recent updates

Third quarter 2024 earnings released: CN¥0.005 loss per share (vs CN¥0.01 profit in 3Q 2023)

Beijing Bohui Innovation Biotechnology Group Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024

We Think Beijing Bohui Innovation Biotechnology Group (SZSE:300318) Is Taking Some Risk With Its Debt

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: CN¥0.01 (vs CN¥0.001 in 2Q 2023)

Beijing Bohui Innovation Biotechnology Group Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Beijing Bohui Innovation Biotechnology Group Co., Ltd., Annual General Meeting, May 17, 2024

First quarter 2024 earnings released: EPS: CN¥0.024 (vs CN¥0.006 in 1Q 2023)

Beijing Bohui Innovation Biotechnology Group Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024

New minor risk - Share price stability

Beijing Bohui Innovation Biotechnology Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024

Third quarter 2023 earnings released: EPS: CN¥0.01 (vs CN¥0.024 loss in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.001 (vs CN¥0.008 loss in 2Q 2022)

High number of new directors

Beijing Bohui Innovation Biotechnology Group Co., Ltd., Annual General Meeting, Jun 29, 2023

First quarter 2023 earnings released: EPS: CN¥0.006 (vs CN¥0.016 loss in 1Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: CN¥0.024 loss per share (vs CN¥0.015 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.008 loss per share (vs CN¥0.007 loss in 2Q 2021)

Beijing Bohui Innovation Biotechnology Group Co., Ltd., Annual General Meeting, Jun 24, 2022

Full year 2021 earnings released: CN¥0.39 loss per share (vs CN¥0.009 profit in FY 2020)

High number of new and inexperienced directors

Third quarter 2021 earnings released: CN¥0.015 loss per share (vs CN¥0.027 profit in 3Q 2020)

Second quarter 2021 earnings released: CN¥0.007 loss per share (vs CN¥0.003 loss in 2Q 2020)

First quarter 2021 earnings released: CN¥0.013 loss per share (vs CN¥0.016 loss in 1Q 2020)

New 90-day low: CN¥8.16

New 90-day low: CN¥9.35

New 90-day low: CN¥11.06

New 90-day low: CN¥13.68

Third quarter earnings released

Beijing Bohui Innovation Biotechnology Co., Ltd. to Report Q3, 2020 Results on Oct 27, 2020

New 90-day high: CN¥15.67

Beijing Bohui Innovation Biotechnology Co., Ltd. (SZSE:300318) signed a share transfer agreement to acquire 50% stake in Changzhou Linghang Quantum Biomedical Technology Co., Ltd. from Gao Sheng, Tu Mingyu and Yang Wanbin for CNY 24 million.

First half earnings released

Beijing Bohui Innovation Biotechnology Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

New 90-day high - CN¥8.26

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd